Navigation Links
HeartWare Presentation At The Canaccord Genuity Medical Technology & Diagnostics Forum To Be Webcast
Date:11/8/2013

FRAMINGHAM, Mass., Nov. 8, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity Medical Technology & Diagnostics Forum at 1:30 p.m. ET on Thursday, November 14, 2013.  The one-day conference is being held at the Westin Grand Central in New York City.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  A replay of the webcast will be available for 90 days at the site after the presentation.

About HeartWare International
HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. The HeartWare System is approved in the United States for the intended use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure, has received CE Marking in the European Union and has been used to treat patients in 36 international countries. The device is also currently the subject of a U.S. clinical trial for destination therapy. For additional information, please visit the Company's website at www.heartware.com'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. HeartWare International Reports $54.8 Million In Third Quarter 2013 Revenue; 140% Increase From Third Quarter Of 2012
2. HeartWare Receives FDA Approval To Enroll Supplemental Patient Cohort In Destination Therapy Trial
3. HeartWare Presentation At The Canaccord Genuity 2013 Annual Growth Conference To Be Webcast
4. HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
5. HeartWare Presentation at the Wells Fargo Securities 2013 Healthcare Conference to be Webcast
6. HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)
7. HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast
8. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
9. HeartWare Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to be Webcast
10. HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
11. HeartWare Schedules First Quarter Conference Call And Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)...  Luminex Corporation (Nasdaq: LMNX ) today announced that ... 2013 on Monday, February 3, 2014. A press release announcing ... trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... highlights and financial results for the fourth quarter and twelve ...
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of GMH ... Medical Equipment, Inc. ("Progressive") of Clarion, PA ... were not disclosed. Progressive is a full ... of sleep, mobility, and respiratory products to customers in the ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... ATLANTA, April 7, 2011 Vystar® Corporation ... Natural Rubber Latex (NRL), a patented, all-natural raw ... other non-rubbers found in natural rubber latex, has ... (Logo: http://photos.prnewswire.com/prnh/20100203/CL48049LOGO) Ms. Kearney ...
... Harriet Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, ... of the Company,s therapeutic and preventative HIV vaccines at the ... Convention Center in Washington DC on Thursday, April 14.  Dr. ... a.m., will cover the topic of recombinant viruses as vaccines. ...
Cached Medicine Technology:Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 2Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 3GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 2GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 3
(Date:4/23/2014)... targets an important brain receptor has a dramatic effect ... behavior, a University at Buffalo animal study has found. ... be a novel lead compound for treating cocaine addiction, ... was published as an online preview article in ... compound, RO5263397, severely blunted a broad range of cocaine ...
(Date:4/23/2014)... science, "simple and accessible detection methods that can ... resolution of a single cell inside that population ... engineer Chang Lu. , In the Royal Society ... has announced that he and his coworkers have ... location of a protein ( Chem. Sci. , ...
(Date:4/23/2014)... - In a country as wealthy as the United States, ... seniors do not have access to adequate food due to ... insecure. , Recent research at the University of Illinois ... (NHANES) revealed that the seniors who are dealing with hunger ... "In 2011, 8.35 percent of Americans over age 60 faced ...
(Date:4/23/2014)... Effects of Midlife Occupational and Leisure Time Physical Activity ... physical activity in midlife increases the risk of mobility ... the risk. This is found in a study which ... The study was conducted at the Gerontology Research Center ... , Heavy physical labor is often repetitive, wears the ...
(Date:4/23/2014)... Getting to the bottom of Alzheimer,s disease has ... turns and controversies. In the latest crook in ... insight into the interaction between proteins associated with ... journal ACS Chemical Neuroscience , could have ... K. Surewicz, Krzysztof Nieznanski and colleagues explain that ...
Breaking Medicine News(10 mins):Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2
... , NASHVILLE, Tenn., July 29 HCA Inc. ... 2009. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20050825/CLTH069LOGO ... , Revenues increased 7.2 percent to $7.483 ... $282 million, compared to $141 million in the prior year,s second quarter. , ...
... ... first of its kind in the world , ... Clifton, NJ (PRWEB) July 28, 2009 -- Announcing the first HelpDesk for ... ,Proper clinical research is the only means to bring modern science and technology to diseased ...
... ... training program designed to help medical transcriptionists prepare to take the Registered Medical Transcriptionist ... ... leading online healthcare education company, has released a new online training program designed to ...
... ... the current economy: Vast amounts of vacancies and subleases are driving down initial rents ... ... International Tenant Representative Alliance , the current downturn in the economy provides a ...
... , , , ... more than 49,000 viewers, Family Research Council Action President Tony ... in five key states including Pennsylvania, Arkansas, Alaska, Louisiana, and Nebraska. ... Obama,s plan become reality - rationing and taxpayer funded abortions. ...
... , , EXTON, Pa., July 28 ... report assessing awareness of the Centers for Medicare and ... Medical Directors and Renal Administrators in dialysis units across ... affiliated with large dialysis chains (i.e. Fresenius, DaVita, DCI) ...
Cached Medicine News:Health News:HCA Reports Second Quarter 2009 Results 2Health News:HCA Reports Second Quarter 2009 Results 3Health News:HCA Reports Second Quarter 2009 Results 4Health News:HCA Reports Second Quarter 2009 Results 5Health News:HCA Reports Second Quarter 2009 Results 6Health News:HCA Reports Second Quarter 2009 Results 7Health News:HCA Reports Second Quarter 2009 Results 8Health News:HCA Reports Second Quarter 2009 Results 9Health News:HCA Reports Second Quarter 2009 Results 10Health News:HCA Reports Second Quarter 2009 Results 11Health News:HCA Reports Second Quarter 2009 Results 12Health News:HCA Reports Second Quarter 2009 Results 13Health News:HCA Reports Second Quarter 2009 Results 14Health News:Career Step Launches New Exam Prep Course for Medical Transcription Industry Credential 2Health News:This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 2Health News:This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 3Health News:FRC Action Launches TV Ad Campaign On Government Health Care Takeover 2Health News:New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011 2
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
One piece, 100% fused silica construction offers low scatter and high efficiency...
... truly lateral, all quartz fiber. The design ... technology for Total Internal Reflection (TIR) at ... output is virtually indistinguishable from an axial ... in a round spot of low divergence. ...
The new series of Steris Power-lift Stirrups incorporate all of the proven clinical benefits of Allen-style booted stirrups: maximum safety for the patient, ease of setup for your staff, impressive v...
Medicine Products: